CDKN2A and neoplasm: Concerning patient- and tumor-related characteristics, lower levels of caspase-8 detection were more prevalent in patients with a higher T-stage (p = 0.002) and FIGO category (p = 0.003), whereas no significant differences were observed for age, N- and M-stage, tumor grading and p16INK4a expression (Table 2).